Prevalence of N-methyl-D-aspartate receptor autoantibodies in the peripheral blood: Healthy control samples revisited

JAMA Psychiatry

Volumn 71, Issue 7, 2014, Pages 838-839

  Steiner, Johann ^a,b   Teegen, Bianca ^c   Schiltz, Kolja ^a,b   Bernstein, Hans Gert ^a   Stoecker, Winfried ^c   Bogerts, Bernhard ^a,b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b Center for Behavioral Brain Sciences   (Germany)

^c Institute of Experimental Immunology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR ANTIBODY;

ANTIBODY BLOOD LEVEL; BIOCHIP; BLOOD SAMPLING; BORDERLINE STATE; CASE CONTROL STUDY; CELL ASSAY; CONTROLLED STUDY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN BLOOD LEVEL; LETTER; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MENTAL PATIENT; REPRODUCIBILITY; SCHIZOPHRENIA; SEROPREVALENCE; TEST RETEST RELIABILITY; BIOSYNTHESIS; BLOOD; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STANDARDS; TRENDS;

AUTOANTIBODIES; BORDERLINE PERSONALITY DISORDER; DEPRESSIVE DISORDER, MAJOR; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; PREVALENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, N-METHYL-D-ASPARTATE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY;

EID: 84903954208     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2014.469     Document Type: Letter

References (7)

1. Steiner J,WalterM, GlanzW, et al. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. JAMA Psychiatry. 2013;70(3):271-278.
2. Hammer C, Stepniak B, Schneider A, et al. Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity [published online September 3, 2013]. Mol Psychiatry. doi:10.1038/mp.2013.110.
3. Dalmau J, Lancaster E, Martinez-Hernandez E, RosenfeldMR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10(1):63-74.
4. WinterWE, Schatz DA. Autoimmune markers in diabetes. Clin Chem. 2011;57 (2):168-175.
5. Abeles AM, Abeles M. The clinical utility of a positive antinuclear antibody test result. Am J Med. 2013;126(4):342-348.
6. Gresa-Arribas N, Titulaer MJ, Torrents A, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2014;13(2):167-177.
7. Tsutsui K, Kanbayashi T, Tanaka K, et al. Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features. BMC Psychiatry. 2012;12(1):37.